Data Elements: vsm_blog14.aspx

MARKEN OPENS BRAZIL DEPOT

New Depot Brings Marken Near Completion of Global Depot Network

 

 

Research Triangle Park, North Carolina, August 5, 2014 -- Marken announced today the opening of their newest clinical trials depot in Sao Paulo Brazil.

Brazil is the 8th of the 10 currently planned purpose-built depots within Marken’s network around the world. The new depot in Brazil, combined with new depots opening shortly in Chile and Peru, completes Marken’s second-phase global network design.  The three new depots in South America also provide the square footage needed for the storage and distribution of clinical trial materials in the Latin America region.  As with all other Marken depots, the new Brazil depot is cGMP/GDP compliant and will be co-located with its logistics operations, near the Congonhas (CGH) Airport.  The Brazil facility will also operate under Marken’s global and fully validated 21CFR Part 11 proprietary software, SOLO.  The SOLO IT platform is a state-of-the-industry inventory management system which interfaces with Marken’s client systems for improved inventory reconciliation at the patient level and can be accessed in  real-time data from anywhere in the world. 

The new depot will offer temperature controlled storage at all levels from 2-8 deg C, controlled room temperature and -20C.  The depot will offer drug receipt, pick and pack, dispatch and drug return/destruction services.   Gerit Offenhauser, Senior Vice President, Clinical Trials Distribution, said this, “The opening of our newest depot in Brazil brings us one step closer to the completion of our strategic depot growth plan that was put into place two years ago.”

“Our commitment, passion, and service to the support of clinical trials storage and distribution are unsurpassed by any other logistics provider.  We remain 100% dedicated to the pharma and life sciences industry and we will continue to provide full service to our clients throughout every step of the clinical trial logistics process,” said Wes Wheeler, Chief Executive Office for Marken.  Wes will personally be hosting the official opening and interactive supply chain workshop taking place on Thursday, August 7 at the Sao Paulo facility.  Focusing on the discussion of The Challenges of Conducting Clinical Trials with Biologics & Biosimilars in Latin America, the workshop will include a depot tour and industry speakers.  For more information or to reserve a seat to the event, email RSVP.MarkenWorkshop@Marken.com.

 

About Marken

Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates depot and logistics into solutions that extend the reach of clinical trials to even the most remote treatment-naive geographies.

News | Monday, March 30, 2015 at 5:29 AM

Regulatory Update: The Korean Toxic Chemicals Control Act (TCCA)
On January 1, 2015 The Korean Toxic Chemicals Control Act (TCCA), which has been in force since 1991 and governs the manufacture, import, and general handling of regulated chemicals, was split Into two separate regulatory policies: the Act ...Read More

News | Thursday, March 26, 2015 at 9:47 AM

Marken Talks to Pharmaceutical Online About Challenges Facing the Antibody Drug Conjugate (ADC) Market
Dan Bell, Marken’s Vice President of Regulatory Compliance and Technical Affairs, talks to Pharmaceutical Online about challenges for the antibody drug conjugate (ADC) market. Read Part One of this two-part series of articles here. Read More

Press Releases | Wednesday, March 25, 2015 at 5:00 AM

featured_image
Marken Wins As Best Life Science Logistics Service Provider Second Year In A Row
Winner Announced at Annual BioPharma Asia Industry Event Research Triangle Park, North Carolina, March 25, 2015 – Marken announced today that they won the pharmaceutical clinical research industry award of Best Life Science Logistics Provide...Read More

Press Releases | Monday, March 23, 2015 at 5:15 PM

featured_image
Marken Announces New Shanghai Office
Opening Joins the Existing Beijing Office for an Expanded Presence in China Research Triangle Park, North Carolina, March 23, 2015 – Marken announced today the opening of their brand new office in Shanghai, China. The logistics operations ...Read More

News | Tuesday, March 17, 2015 at 10:31 AM

featured_image
Marken’s New Brazil Depot Supports Increased Focus on Clinical Trials in Brazil
Marken’s New Brazil Depot Supports Increased Focus on Clinical Trials in Brazil   The Most Advanced Depot Network in the Industry New legislation in Brazil released March 3, 2015 will speed up the approval process for clinical tri...Read More

News | Wednesday, March 11, 2015 at 1:24 PM

Marken Regulatory Update: Ukraine Introduces Temporary Import Surcharge
  Companies importing goods into Ukraine will now have to pay an additional import surcharge.   On February 25, 2015 the ‘Law of Ukraine on measures to stabilize the balance of payments No.73-VIII’[1]  went in...Read More

News | Tuesday, March 03, 2015 at 1:05 PM

Marken Regulatory Update: Australia Releases New Guidance on Release for Supply for Medical Product Manufactures, Clarifying GMP Responsibilities of the Authorized Person
Australia’s Therapeutic Goods Agency (TGA) added another guidance document to their already robust list of industry guidelines[i].  The Guidance covering Release for Supply for Medical Product Manufactures, published on January 23, 2015, c...Read More

News | Wednesday, February 25, 2015 at 8:23 AM

Marken Export Compliance Update: Clinical Samples from Mexico
Ensuring delivery of clinical samples to labs outside of Mexico are on time and within temperature spec. requires close attention to, and compliance with, current export regulations. Exports of clinical samples from Mexico are subject to specific ...Read More

News | Monday, February 23, 2015 at 9:50 AM

Summary of the Drug Supply Chain Security Act (DSCSA)
  Purpose In November of 2013, the United States Food and Drug Administration (FDA) passed the Drug Supply Chain Security Act (DSCSA). The DSCSA was created to strengthen the security of the drug distribution supply chain by adding contro...Read More

Press Releases | Wednesday, February 18, 2015 at 6:00 AM

featured_image
Marken Announces New Moscow Technical Director
  Role Expands Marken’s Presence in Key Russian Market     Research Triangle Park, North Carolina, February 18, 2015 -- Marken announced today the appointment of Ms. Anastacia Kurianova as Technical Director, Marken ...Read More

The Stories of Marken

View All Stories

Global Pharma Supply Chain Solutions

Data Elements: ucUserControlCaseStudiesHome.aspx
marken video